Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
McKinsey
Boehringer Ingelheim
Express Scripts
Chinese Patent Office
Citi
Fish and Richardson
Accenture
QuintilesIMS

Generated: April 24, 2018

DrugPatentWatch Database Preview

REVEX Drug Profile

« Back to Dashboard

Which patents cover Revex, and what generic alternatives are available?

Revex is a drug marketed by Eurohlth Intl Sarl and is included in one NDA.

The generic ingredient in REVEX is nalmefene hydrochloride. There are four drug master file entries for this compound. Additional details are available on the nalmefene hydrochloride profile page.
Drug patent expirations by year for REVEX
Synonyms for REVEX
(-)-Nalmefene
(1S,5R,13S,17S)-4-(cyclopropylmethyl)-14-methylidene-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7,9,11(18)-triene-10,17-diol
(1S,5R,13S,17S)-4-(CYCLOPROPYLMETHYL)-14-METHYLIDENE-12-OXA-4-AZAPENTACYCLO[9.6.1.0(1),(1)(3).0?,(1)?.0?,(1)?]OCTADECA-7(18),8,10-TRIENE-10,17-DIOL
(4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylidene-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol,hydrochloride
(5?)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinan-3,14-diol hydrochloride
(5|A)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinan-3,14-diol
(5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinan-3,14-diol
(5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinon-3,14-diol
(5alpha)-17-(cyclopropylmethyl)-6-methylidene-4,5-epoxymorphinan-3,14-diol
096N269
17-(Cyclopropylmethyl)-4,5alpha-epoxy-6-methylenemorphinan-3,14-diol
17-(Cyclopropylmethyl)-4,5alpha-epoxy-6-methylenemorphinan-3,14-diol, , hydrochloride
55096-26-9
55096-26-9 (Parent)
58895-64-0
58895-64-0 (hydrochloride)
6-Deoxo-6-methylenenaltrexone
6-Desoxy-6-methylenenaltrexone
9a-(Cyclopropylmethyl)-4,5alpha-epoxy-6-methylen-3,14-morphinandiol
AB00384250_10
AK167620
AKOS016340557
Alcofene
AN-39745
AN-40433
Arthene
B5505
B7584
BDBM50045776
C08027
CAS-55096-26-9
CCG-221179
Cervene
Cessal
CHEBI:7457
CHEMBL1201152
CHEMBL982
cid_5284594
D02104
D05111
D05VIL
DSSTox_CID_3347
DSSTox_GSID_23347
DSSTox_RID_76985
DTXSID8023347
FT-0689460
GTPL1628
GYWMRGWFQPSQLK-OPHZJPRHSA-N
HMS2232D07
HS-0037
HSDB 6761
Incystene
JF 1
JF-1
K7K69QC05X
LS-183737
LS-91713
MFCD00133650
MFCD07772293
MLS000069366
MolPort-023-277-063
Morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-methylene-, (5alpha)-
Morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-methylene-, hydrochloride, (5alpha)-
nalmefene
Nalmefene - d3
Nalmefene (USAN/INN)
Nalmefene [USAN:BAN:INN]
Nalmefene [USAN:INN:BAN]
Nalmefene HCl
Nalmefene hydrochloride
Nalmefenehydrochloride
Nalmefeno
Nalmefeno [INN-Spanish]
Nalmefenum
Nalmefenum [INN-Latin]
Nalmetrene
Nalmetreno
Nalmetreno [INN-Spanish]
Nalmetrenum
Nalmetrenum [INN-Latin]
NCGC00021666-03
NCGC00021666-04
NIH-10365
Opera_ID_468
ORF 11676
ORF-11676
PDSP2_001543
PL000926
Revex (nalmefene hydrochloride)
Revex (TN)
SCHEMBL17075347
SCHEMBL35230
SCHEMBL628721
Selincro
Selincro (TN)
SMR000058884
Soberal
SR-01000000007
SR-01000000007-2
TOV02TDP9I
Tox21_110873
Tox21_110873_1
UNII-K7K69QC05X
UNII-TOV02TDP9I
WJBLNOPPDWQMCH-MBPVOVBZSA-N
ZINC403529

US Patents and Regulatory Information for REVEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eurohlth Intl Sarl REVEX nalmefene hydrochloride INJECTABLE;INJECTION 020459-001 Apr 17, 1995 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Eurohlth Intl Sarl REVEX nalmefene hydrochloride INJECTABLE;INJECTION 020459-002 Apr 17, 1995 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
US Army
McKinsey
Daiichi Sankyo
Moodys
Merck
Teva
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.